Skip to content

Androgen deprivation therapy may reduce the risk of primary open-angle glaucoma in patients with prostate cancer: a nationwide population-based cohort study.

Cohort study (title) · Prostate Int · 2021. Source record refreshed; an explanation has not been reviewed.

Cohort study (title)Source: PubMed · PMID 35059357

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Androgen deprivation therapy may reduce the risk of primary open-angle glaucoma in patients with prostate cancer: a nationwide population-based cohort study.

Ahn HK, Lee HS, Park JY et al.
Prostate Int · 2021

PubMed ID
35059357
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.